RSV Hospitalization Prevention: Abrysvo® Vaccine Study

We are studying whether the Abrysvo® vaccine can help prevent hospitalizations from RSV in adults aged 18 and older, especially those 60 and above. This research aims to improve respiratory health outcomes in older adults.

6-12 months ≤5 visits Monitoring phase (IV)No Placebo Standard Medicines InjectionInfectious DiseasesPulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Abrysvo

Abrysvo is a vaccine that helps prevent RSV lung infections in older adults and can protect newborns when given during pregnancy.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Respiratory Syncytial Virus

Stabilized Prefusion F Protein 847a

Stabilized Prefusion F Protein 847a is a protein used in vaccines to trigger immune protection against respiratory syncytial virus infections.

Stabilized Prefusion F Protein 847b

Stabilized Prefusion F Protein 847b is a vaccine antigen that helps the immune system recognize and prevent certain viral respiratory infections.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Gentofte Hospital

Department of Cardiology

Charlottenlund, Denmark

Danske Lægers Vaccinations Service

Kongens Lyngby, Denmark

Complexo Hospitalario Universitario De Santiago

Pediatrics

Santiago de Compostela, Spain

Sponsor: Gentofte Hospital

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.